Combination Therapy Versus Celecoxib, a Single Selective COX-2 Agent, to Reduce Gastrointestinal Toxicity in Arthritic Patients: Patient and Cost-Effectiveness Considerations

Open Access Rheumatology: Research and Reviews - New Zealand
doi 10.2147/oarrr.s14568
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Informa UK Limited

Related search

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

Cost-Effectiveness of First-Line Versus Delayed Use of Combination Dapagliflozin and Metformin in Patients With Type 2 Diabetes

Scientific Reports
Multidisciplinary
2019English

Cost-Effectiveness Analysis of Continuous Versus Intermittent Celecoxib Use for HIP and Knee Osteoarthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Cost-Effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2010English

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Risk of Gastrointestinal Effects With COX-2 Inhibitors and NSAIDs: Study Conclusions Do Not Reflect Findings for Celecoxib

BMJ
2005English

5-Fu Therapeutic Drug Monitoring as a Valuable Option to Reduce Toxicity in Patients With Gastrointestinal Cancer

Oncotarget
Oncology
2018English

Overexpression of COX-2 in Celecoxib-Resistant Breast Cancer Cell Lines

Journal of Surgical Research
Surgery
2010English

Risk of Gastrointestinal Effects With COX-2 Inhibitors and NSAIDs: What Does Evidence From Randomised Trials Show About Celecoxib?

BMJ
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy